Advertisement Plandai signs Phytofare distribution deal with NutraGenesis - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Plandai signs Phytofare distribution deal with NutraGenesis

Plandai Biotechnology has signed a distribution deal scheduled for three years with NutraGenesis for the commercialization of Phytofare extracts.

Through the deal, NutraGenesis gains exclusive rights to market Plandai’s patented Phytofare extracts in North America.

Plandai marketing sales vice-president and global director Callum Baylis-Duffield said, "This is just one of a number of regional distribution relationships that we expect to announce that will introduce Phytofare to customers in a variety of markets worldwide."

The company’s proprietary plant extracts such as Phytofare Catechin Extract, Phytofare Glucoside Complex and Phytofare Carotenoid Extract, have demonstrated improved bioavailability in USDA studies.

NutraGenesis president Suzanne McNeary said, "NutraGenesis believes that Plandai’s extracts will be well-received by our client base in North America."